dorsaVi Ltd (ASX:DVL)
Australia · Delayed Price · Currency is AUD 0.0230
0.00 (0.00%)
Aug 11, 2026, 2:09 PM AEST
dorsaVi Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 1 | 1.13 | 1.3 | 1.75 | 2.35 | 1.87 |
Revenue Growth | -11.53% | -13.40% | -25.49% | -25.62% | 25.91% | -7.44% |
Gross Profit Gross Profit Growth | 0.84 | 0.97 | 1.18 | 1.5 | 2.08 | 1.7 |
Operating Income Operating Income Growth | -4.95 | -1.88 | -1.69 | -2.3 | -2.68 | -2.53 |
Net Income Net Income Growth | -4.53 | -1.52 | -1.25 | -1.82 | -1.54 | -2.41 |
Earnings Per Share EPS Growth | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Workplace Workplace Growth | 0.17 | 0.28 | 0.34 | 0.7 | 0.73 | 0.74 |
Clinical Clinical Growth | 0.83 | 0.84 | 0.96 | 1.05 | 1.63 | 1.13 |
Total Total Growth | 1 | 1.13 | 1.3 | 1.75 | 2.35 | 1.87 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 4.95 | 2.29 | 0.48 | 0.88 | 0.45 | 2.8 |
Total Debt Total Debt Growth | 0.09 | 0.16 | 0.19 | 0.32 | 1.18 | 1.18 |
Net Cash (Debt) Net Cash Growth | 4.86 | 2.14 | 0.29 | 0.56 | -0.73 | 1.61 |
Net Cash Growth | 127.51% | 642.08% | -48.30% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.01 | 0.00 | 0.00 | 0.00 | -0.00 | 0.01 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -2.68 | -0.96 | -0.6 | -0.97 | -2.15 | -2.27 |
Capital Expenditures CapEx Growth | - | - | -0 | -0.01 | -0.06 | -0.05 |
Free Cash Flow Free Cash Flow Growth | -2.68 | -0.96 | -0.6 | -0.98 | -2.22 | -2.32 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 83.95% | 86.04% | 90.53% | 85.68% | 88.19% | 91.10% |
Operating Margin | -495.42% | -166.50% | -129.77% | -131.27% | -114.03% | -135.53% |
Pretax Margin | -488.51% | -165.90% | -130.66% | -131.79% | -89.17% | -151.46% |
Profit Margin | -452.87% | -134.38% | -95.66% | -104.01% | -65.28% | -129.10% |
FCF Margin | -268.45% | -84.71% | -46.32% | -56.13% | -94.29% | -124.25% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Forward PE | - | 21.14 | 21.14 | 21.14 | 21.14 | 21.14 |
PS Ratio | 27.85 | 11.17 | 5.19 | 3.48 | 1.82 | 5.07 |